Description
Orzeyful contains oveporexton, a first-in-class oral orexin receptor 2 (OX2R) agonist designed to address reduced orexin signaling associated with narcolepsy type 1. Unlike medicines that primarily manage individual symptoms, oveporexton directly stimulates OX2R to help restore the wakefulness signaling pathway.
Orzeyful is approved for adults with narcolepsy type 1 (narcolepsy with cataplexy). Clinical studies demonstrated improvements in wakefulness, excessive daytime sleepiness, cataplexy, and other symptoms associated with NT1.
Product Introduction
Uses of Orzeyful 2 mg
- Used for the treatment of narcolepsy type 1 in adults.
- Helps address excessive daytime sleepiness associated with NT1.
- Helps reduce cataplexy episodes and other symptoms associated with NT1.
Benefits in Treatment
- Activates orexin receptor 2 (OX2R).
- Helps restore orexin signaling involved in wakefulness.
- May improve daytime wakefulness and reduce excessive sleepiness.
- Provides an approach targeting the underlying orexin deficiency associated with narcolepsy type 1.
Side Effects of Orzeyful
Commonly reported adverse effects include insomnia, increased urinary frequency, urinary urgency, and increased saliva production. Patients should discuss other medicines with their healthcare professional because Orzeyful has important drug-interaction considerations, including contraindication with strong CYP3A inhibitors.
Quick Tips
- Use Orzeyful strictly according to the prescribing physician’s instructions.
- Do not change the dose or dosing schedule without medical advice.
- Inform your healthcare professional about all medicines and supplements you are taking.
- Follow the recommended storage conditions.
- This is a prescription medicine and should be used under appropriate medical supervision.
To Order
Reviews
There are no reviews yet.